Understanding Clinical Innovation

Here’s how clinical innovation translates to a new drug’s success:

Chronic Disease Insights

Featured
Suzetrigine drivers.jpg
Journavx, Acute pain, Opioid, Vertex
Journavx, a vast improvement over opioids in moderate acute pain
Journavx, Acute pain, Opioid, Vertex
Read More →
Journavx, Acute pain, Opioid, Vertex
Xolair-Figure JPG.jpg
Xolair, Food allergy, Genentech, Novartis
Xolair for food allergies: effective therapy at a high price
Xolair, Food allergy, Genentech, Novartis
Read More →
Xolair, Food allergy, Genentech, Novartis
Leqembi-Figure.jpg
Leqembi, Aduhelm, donanemab, Alzheimer's Disease, Eisai, Biogen, Eli Lilly
Monoclonal antibodies for Alzheimer’s disease: questionable clinical benefit at a high price
Leqembi, Aduhelm, donanemab, Alzheimer's Disease, Eisai, Biogen, Eli Lilly
Read More →
Leqembi, Aduhelm, donanemab, Alzheimer's Disease, Eisai, Biogen, Eli Lilly
Evrysdi-figure.jpg
Zolgensma, Spinraza, Evrysdi, Biogen, Novartis, Roche, SMA Type 1, Spinal Muscular Atrophy
Evrysdi: A Potential Game-Changer for SMA Type 1 Patients
Zolgensma, Spinraza, Evrysdi, Biogen, Novartis, Roche, SMA Type 1, Spinal Muscular Atrophy
Read More →
Zolgensma, Spinraza, Evrysdi, Biogen, Novartis, Roche, SMA Type 1, Spinal Muscular Atrophy
Risperidone-vs.-Ulatorant.jpg
ulotaront, Sunovion, Lybalvi, schizophrenia, risperidone, Alkermes
Prospects for ulotaront in schizophrenia
ulotaront, Sunovion, Lybalvi, schizophrenia, risperidone, Alkermes
Read More →
ulotaront, Sunovion, Lybalvi, schizophrenia, risperidone, Alkermes
Drivers.JPG
Trikafta, Cystic Fybrosis, Vertex
Trikafta: A Major Step Forward for Cystic Fibrosis Patients
Trikafta, Cystic Fybrosis, Vertex
Read More →
Trikafta, Cystic Fybrosis, Vertex
Screenshot 2025-08-06 090503.png
radicava, ALS, edaravone, riluzole
Radicava: Not Innovative Enough to Sustain Strong Start
radicava, ALS, edaravone, riluzole
Read More →
radicava, ALS, edaravone, riluzole
Capture.JPG
Hemlibra, Hemophilia A, Advate, emicizumab
Hemlibra: A Strong Leader in Hemophilia A
Hemlibra, Hemophilia A, Advate, emicizumab
Read More →
Hemlibra, Hemophilia A, Advate, emicizumab
Capture.JPG
Oral semaglutide: A game changer in type 2 diabetes
Read More →
Tymlos, osteoporosis, ACTIVE, pharma
Tymlos: A new force in the osteoporosis market
Tymlos, osteoporosis, ACTIVE, pharma
Read More →
Tymlos, osteoporosis, ACTIVE, pharma
Capture.JPG
Xeljanz, ulcerative colitis, pharma
Xeljanz: Is ulcerative colitis finally the place for JAKs to shine?
Xeljanz, ulcerative colitis, pharma
Read More →
Xeljanz, ulcerative colitis, pharma
MS 1.JPG
Gilenya, Aubagio, and Tecfidera in Multiple Sclerosis
Read More →
jardiance.jpg
Jardiance: New outcomes data in type 2 diabetes
Read More →
Brintellix: Another "me too" in major depression
Read More →
Pradaxa: Stroke prevention in atrial fibrillation
Read More →
Stelara: Exceeding expectations in psoriasis
Read More →
Pristiq: no innovation in major depressive disorder
Read More →
Benlysta in SLE: A cautionary tale
Read More →